CONCORD
Start SIP
Invest Now
Start SIP in CONCORD
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
- 50 DMA₹79.59
- 100 DMA₹73.83
- 200 DMA₹63.73
Investment Returns
- Over 1 Month -12.01%
- Over 3 Month + 12.19%
- Over 6 Month + 27.51%
- Over 1 Year + 92.87%
Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!
Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Concord Drugs Financials
Concord Drugs Technicals
EMA & SMA
Current Price
₹73.00
-1.16
(-1.56%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹80.52
- 50 Day
- ₹79.59
- 100 Day
- ₹73.83
- 200 Day
- ₹63.73
Resistance and Support
72.7
- R3 77.50
- R2 75.80
- R1 74.40
- S1 71.30
- S2 69.60
- S3 68.20
Concord Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-07-03 | Preferential issue of shares | |
| 2025-06-27 | Preferential Issue of shares & Others | Inter-alia, to consider 1. the date, time, and venue for convening an ExtraOrdinary General Meeting of the Company. 2. Other business matters. |
| 2025-05-23 | Audited Results |
Concord Drugs F&O
About Concord Drugs
- NSE Symbol
- CONCORD
- BSE Symbol
- 538965
- Chairman & Managing Director
- Mr. Sudhir Vaid
- ISIN
- INE858L01010
Similar Stocks to Concord Drugs
Concord Drugs FAQs
Concord Drugs share price is ₹73 As on 25 January, 2026 | 06:53
The Market Cap of Concord Drugs is ₹96.2 Cr As on 25 January, 2026 | 06:53
The P/E ratio of Concord Drugs is 167.1 As on 25 January, 2026 | 06:53
The PB ratio of Concord Drugs is 2.6 As on 25 January, 2026 | 06:53
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.